These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 14358013

  • 21. Waning antibody levels and avidity: implications for MMR vaccine-induced protection.
    Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I.
    J Infect Dis; 2012 Nov 15; 206(10):1542-8. PubMed ID: 22966129
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA.
    Pediatrics; 1986 Oct 15; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [Abstract] [Full Text] [Related]

  • 24. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI, Nakamura MA, Godoy MV, Kuri P, Lucas CA, Conyer RT.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Medical students as sources of rubella and measles outbreaks.
    Poland GA, Nichol KL.
    Arch Intern Med; 1990 Jan 01; 150(1):44-6. PubMed ID: 2297297
    [Abstract] [Full Text] [Related]

  • 29. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH, Saracen CL, Peter G.
    Pediatrics; 1994 Oct 01; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 34. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K, Duraj V, Ljungman P, Sjölin J, Oberg G, Lönnerholm G, Fridell E, Smedmyr B, Simonsson B.
    Bone Marrow Transplant; 1992 Jun 24; 9(6):427-32. PubMed ID: 1628126
    [Abstract] [Full Text] [Related]

  • 35. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ, Orenstein WA, Hinman AR.
    Dev Biol Stand; 1986 Jun 24; 65():45-52. PubMed ID: 3104117
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Evolution of measles, rubella and mumps from the third seroepidemiological survey in the autonomous region of Madrid, Spain].
    Sanz Moreno JC, García Comas L, Ramírez Fernández R, Ramos Blázquez B, Ordobás Gavín M.
    Rev Esp Salud Publica; 2009 Jun 24; 83(5):625-37. PubMed ID: 20111811
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.